Evert Schimmelpennink - Jul 22, 2024 Form 4 Insider Report for LENZ Therapeutics, Inc. (GRPH)

Role
President, CEO and Secretary, Director
Signature
/s/ Evert Schimmelpennink
Stock symbol
GRPH
Transactions as of
Jul 22, 2024
Transactions value $
$46,800
Form type
4
Date filed
7/23/2024, 08:16 PM
Previous filing
May 29, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GRPH Common Stock Options Exercise $46.8K +45K $1.04* 45K Jul 22, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GRPH Stock Option (right to buy) Options Exercise $0 -45K -11.62% $0.00 342K Jul 22, 2024 Common Stock 45K $1.04 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares issued pursuant to the LENZ Therapeutics Operations, Inc. (previously named Lenz Therapeutics, Inc.) 2020 Equity Incentive Plan (the "2020 Plan"). Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2020 Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean March 8, 2021.

Remarks:

Exhibit 24 - Power of Attorney